Large-scale testing (Phase 3)UnknownNCT00532818What this trial is testingHydralazine Valproate for Cervical CancerWho this might be right forMetastatic Cervical Cancer National Institute of Cancerología 143
Testing effectiveness (Phase 2)WithdrawnNCT05614453What this trial is testingTislelizumab in Combination With Sitravatinib for Recurrent/Metastatic Cervical Cancer After Platinum-Based ChemotherapyWho this might be right forMetastatic Cervical Cancer Australia New Zealand Gynaecological Oncology Group
Not applicableStudy completedNCT03301493What this trial is testingGenomic Testing and Resulting Medical DecisionsWho this might be right forCancer of Unknown OriginCancer RefractoryCancer of Stomach+12 more Arbeitsgemeinschaft medikamentoese Tumortherapie 1,500
Not applicableNot Yet RecruitingNCT07186868What this trial is testingQL706 + Chemo ± Bevacizumab in Anti-PD-(L)1-Resistant R/M Cervical CancerWho this might be right forRecurrent Cervical CancerMetastatic Cervical Cancer Cancer Institute and Hospital, Chinese Academy of Medical Sciences 25
Testing effectiveness (Phase 2)Study completedNCT04380805What this trial is testingAK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical CancerWho this might be right forRecurrent Cervical CancerMetastatic Cervical Cancer Akeso 30
Testing effectiveness (Phase 2)Study completedNCT00319748What this trial is testingStudy of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical CancersWho this might be right forBreast CancerOvarian CancerEndometrial Cancer+1 more Masonic Cancer Center, University of Minnesota 15
Testing effectiveness (Phase 2)Looking for participantsNCT07424664What this trial is testingA Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal CancerWho this might be right forUterine Cervical Neoplasms, Recurrent; Uterine Cervical Neoplasms, Metastatic; Vulvar Neoplasms; Vaginal Neoplasms Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Large-scale testing (Phase 3)Active Not RecruitingNCT04906993What this trial is testingCamrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical CancerWho this might be right forCervical Cancer Jiangsu HengRui Medicine Co., Ltd. 443
Testing effectiveness (Phase 2)Study completedNCT00003065What this trial is testingTopotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the CervixWho this might be right forCervical Cancer Herbert Irving Comprehensive Cancer Center 25
Large-scale testing (Phase 3)Study completedNCT03556839What this trial is testingPlatinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the CervixWho this might be right forCarcinoma of the Cervix, Stage IVB Grupo Español de Investigación en Cáncer de Ovario 410
Testing effectiveness (Phase 2)Study completedNCT06226350What this trial is testingA Phase Ⅱ Study of F520 in Patients With Cervical CarcinomaWho this might be right forCervical Cancer Shandong New Time Pharmaceutical Co., LTD 29
Testing effectiveness (Phase 2)Looking for participantsNCT07051486What this trial is testingA Phase II Trial of SHR-A1811 in HER2-Expressing Recurrent/Metastatic Cervical CancerWho this might be right forRecurrent or Metastatic Cervical Cancer Jiangsu HengRui Medicine Co., Ltd. 60
Not applicableUnknownNCT03896958What this trial is testingThe PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Who this might be right forCancer, All TypesCancer of LiverCancer of Stomach+42 more SpeciCare 1,000
Not applicableNot Yet RecruitingNCT07673211What this trial is testingCirculating cfDNA and HPV as Prognostic Biomarkers for First-Line Recurrent Metastatic Cervical CancerWho this might be right forCervical CancerRecurrent Cervical CancerMetastatic Cervical Cancer Zhejiang Cancer Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00057863What this trial is testingOxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical CancerWho this might be right forCervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+3 more National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT06238635What this trial is testingDostarlimab and Cobolimab in Advanced Cervical CancerWho this might be right forCervical CancerAdvanced Cervical CarcinomaMetastatic Cervical Cancer+2 more Meghan Shea 66
Testing effectiveness (Phase 2)Ended earlyNCT00106262What this trial is testingStudy of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal CancerWho this might be right forCervical Cancer Women and Infants Hospital of Rhode Island 38
Testing effectiveness (Phase 2)Looking for participantsNCT05990803What this trial is testingBL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Cervical Cancer and Other Gynecological MalignanciesWho this might be right forCervical Cancer Sichuan Baili Pharmaceutical Co., Ltd. 130
Testing effectiveness (Phase 2)Study completedNCT02095119What this trial is testingA Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical CancerWho this might be right forUterine Cervical Cancer National Institute of Cancerología 15
Testing effectiveness (Phase 2)UnknownNCT03972722What this trial is testingStudy of GLS-010 Injection in Patients With Recurrent or Metastatic Cervical CancerWho this might be right forCervical Cancer Guangzhou Gloria Biosciences Co., Ltd. 89